Abstract:Human cytochrome P450 3A4 (hCYP3A4), one of the most important drug-metabolizing enzymes, catalyze the metabolic clearance of ∼50% therapeutic drugs. CYP3A4 inhibitors have been used for improving the in vivo efficacy of hCYP3A4-substrate drugs. However, most of existing hCYP3A4 inhibitors may trigger serious adverse effects or undesirable effects on endogenous metabolism. This study aimed to discover potent and orally active hCYP3A4 inhibitors from chalcone derivatives and to test their anti-hCYP3A4 effects both in vitro and in vivo. Following three rounds of screening and structural optimization, the isoquinoline chalcones were found with excellently anti-hCYP3A4 effects. SAR studies showed that introducing an isoquinoline ring on the A-ring significantly enhanced anti-CYP3A4 effect, generating A10 (IC50 = 102.10 nM) as a promising lead compound. The 2nd round of SAR studies showed that introducing a substituent group at the para position of the carbonyl group on B-ring strongly improved the anti-CYP3A4 effect. As a result, C6 was identified as the most potent hCYP3A4 inhibitor (IC50 = 43.93 nM) in human liver microsomes (HLMs). C6 also displayed potent anti-hCYP3A4 effect in living cells (IC50 = 153.00 nM), which was superior to the positive inhibitor ketoconazole (IC50 = 251.00 nM). Mechanistic studies revealed that C6 could potently inhibit CYP3A4-catalyzed N-ethyl-1,8-naphthalimide (NEN) hydroxylation in a competitive manner (Ki = 30.00 nM). Moreover, C6 exhibited suitable metabolic stability in HLMs and showed good safety profiles in mice. In vivo tests demonstrated that C6 (100 mg/kg, orally administration) significantly increased the AUC(0-inf) of midazolam by 3.63-fold, and strongly prolonged its half-life by 1.66-fold compared with the vehicle group in mice. Collectively, our findings revealed the SARs of chalcone derivatives as hCYP3A4 inhibitors and offered several potent chalcone-type hCYP3A4 inhibitors, while C6 could serve as a good lead compound for developing novel, orally active CYP3A4 inhibitors with improved druglikeness properties.

Metabolism of Chamaechromone in Vitro with Human Liver Microsomesand Recombinant Human Drug-Metabolizing Enzymes

Metabolites characterization of chamaechromone in vivo and in vitro by using ultra-performance liquid chromatography/Xevo G2 quadrupole time-of-flight tandem mass spectrometry.

CYP450 1A2 and multiple UGT1A isoforms are responsible for jatrorrhizine metabolism in human liver microsomes.

Metabolism of chlorambucil by rat liver microsomal glutathione S-transferase.

Neochamaejasmin B Increases the Bioavailability of Chamaechromone Coexisting in Stellera Chamaejasme L. Via Inhibition of MRP2 and BCRP.

In Vitro Anti-Cancer Activity of Chamaejasmenin B and Neochamaejasmin C Isolated from the Root of Stellera Chamaejasme L

Metabolite profiling and identification of enzymes responsible for the metabolism of hirsutine, a major alkaloid from Uncaria rhynchophylla

Hepatic Glucuronidation of Isoneochamaejasmin A from the Traditional Chinese MedicineStellera ChamaejasmeL. Root

Hepatic Glucuronidation of Isoneochamaejasmin a from the Traditional Chinese Medicine Stellera Chamaejasme L. Root.

Cytochrome P450 mediated metabolic activation of chrysophanol

Stereoselective in Vitro Metabolism of Cyproconazole in Rat Liver Microsomes and Identification of Major Metabolites

A UPLC-MS/MS Method for Simultaneous Determination of Five Flavonoids from Stellera Chamaejasme L. in Rat Plasma and Its Application to a Pharmacokinetic Study.

Enantioselective Metabolism of Four Chiral Triazole Fungicides in Rat Liver Microsomes.

Stereochemistry of Chiral Pesticide Uniconazole and Enantioselective Metabolism in Rat Liver Microsomes.

Metabolic Profiling of Senkyunolide A and Identification of Its Metabolites in Hepatocytes by Ultra-High-performance Liquid Chromatography Combined with Diode-Array Detector and High-Resolution Mass Spectrometry

Screening of Antineoplastic Components in Radix Et Rhizoma Rhei Using Chromatographic Fingerprints

Metabolism schemes of chlorogenic, quinic and caffeic acid derivatives in rats deduced by molecular fragments detected with optimized UPLC-APCI-MS/MS conditions

Design, Synthesis and Biological Evaluation of Chalcone Derivatives As Potent and Orally Active Hcyp3a4 Inhibitors.

Metabolic profiling of five flavonoids from Dragon's Blood in human liver microsomes using high-performance liquid chromatography coupled with high resolution mass spectrometry.

In vitro enantioselective metabolism of TJ0711 hydrochloride by human liver microsomes using a novel chiral liquid chromatography-tandem mass spectrometry method.

Stereoselective degradation of chiral fungicide myclobutanil in rat liver microsomes.